Convenio Medicamentos 2 2019
COTIZAR: PRECIOS UNITARIOS NETOS, SOLO COTIZAR PRODUCTOS CON STOCK PARA DESPACHO INMEDIATO, Y CON VENCIMIENTO MAYOR A 12 MESES SINO ENVIAR CARTA DE CANJE, INDICAR FACTOR EMPAQUE EN CADA LÍNEA COTIZADA E INDICAR EL NOMBRE DE LA MARCA OFERTADA.
19 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058095-2241-SE20 | 17-08-2020 | Ascend Laboratories SpA | $642.600 |
| 1058095-2105-SE20 | 03-08-2020 | Representaciones Gemarkpharma Limitada | $354.144 |
| 1058095-1411-SE20 | 15-05-2020 | Sociedad Farmaceutica Bulfor Limitada | $16.065 |
| 1058095-1217-SE20 | 29-04-2020 | Farmaceutica Insuval S.A. | $238.000 |
| 1058095-975-SE20 | 01-04-2020 | Ascend Laboratories SpA | $1.285.200 |
| 1058095-939-SE20 | 30-03-2020 | Ascend Laboratories SpA | $1.927.800 |
| 1058095-504-SE20 | 02-03-2020 | Laboratorio Biosano S.A. | $750.950 |
| 1058095-501-SE20 | 24-02-2020 | Farmaceutica Insuval S.A. | $119.000 |
| 1058095-581-SE20 | 18-02-2020 | Novofarma Service S.A. | $360.499 |
| 1058095-582-SE20 | 18-02-2020 | Ascend Laboratories SpA | $128.520 |
| 1058095-223-SE20 | 12-02-2020 | Grifols Chile S.A. | $821.219 |
| 1058095-441-SE20 | 10-02-2020 | Sociedad Farmaceutica Bulfor Limitada | $32.130 |
| 1058095-225-SE20 | 31-01-2020 | Ascend Laboratories SpA | $899.640 |
| 1058095-224-SE20 | 31-01-2020 | Laboratorios Andromaco S.A. | $483.235 |
| 1058095-222-SE20 | 29-01-2020 | Novofarma Service S.A. | $1.310.904 |
| 1058095-256-SE20 | 27-01-2020 | Farmaceutica Insuval S.A. | $238.000 |
| 1058095-31-SE20 | 09-01-2020 | Ascend Laboratories SpA | $1.092.420 |
| 1058095-1697-SE19 | 31-12-2019 | Novofarma Service S.A. | $458.816 |
| 1058095-602-SE19 | 31-12-2019 | Laboratorio Biosano S.A. | $750.950 |
| 1058095-603-SE19 | 31-12-2019 | Farmaceutica Insuval S.A. | $238.000 |
| 1058095-1646-SE19 | 23-12-2019 | Grifols Chile S.A. | $123.183 |
| 1058095-1548-SE19 | 11-12-2019 | Ascend Laboratories SpA | $385.560 |
| 1058095-1551-SE19 | 11-12-2019 | Grifols Chile S.A. | $287.427 |
| 1058095-606-SE19 | 18-11-2019 | Novofarma Service S.A. | $196.636 |
| 1058095-1325-SE19 | 18-11-2019 | Ascend Laboratories SpA | $321.300 |
| 1058095-1324-SE19 | 18-11-2019 | Grifols Chile S.A. | $123.183 |
| 1058095-1107-SE19 | 28-10-2019 | Sociedad Farmaceutica Bulfor Limitada | $14.280 |
| 1058095-607-SE19 | 04-10-2019 | Ascend Laboratories SpA | $128.520 |
| 1058095-900-SE19 | 27-09-2019 | Laboratorios Andromaco S.A. | $431.827 |
| 1058095-605-SE19 | 27-09-2019 | Sociedad Farmaceutica Bulfor Limitada | $14.280 |
| 1058095-838-SE19 | 13-09-2019 | Representaciones Gemarkpharma Limitada | $1.283.772 |
| 1058095-629-SE19 | 03-09-2019 | Sociedad Farmaceutica Bulfor Limitada | $14.280 |
| 1058095-609-SE19 | 03-09-2019 | Laboratorios Andromaco S.A. | $186.997 |
| 1058095-608-SE19 | 03-09-2019 | Representaciones Gemarkpharma Limitada | $509.082 |
| 1058095-604-SE19 | 03-09-2019 | Grifols Chile S.A. | $985.463 |
Fuente original:ficha mercadopublico.cl
